The cytotoxic interaction of inorganic trace elements with EDTA and cisplatin in sensitive and resistant human ovarian cancer cells

In Vitro Cellular and Developmental Biology - Animal

Volumn 33, Issue 3, 1997, Pages 218-221

  Maier, Robert H ^a   Purser, Susan M ^a   Nicholson, Daniel L ^a   Pories, Walter J ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

chelating agents; chemotherapy; ovarian cancer; trace metals

Indexed keywords

ANTINEOPLASTIC AGENT; BISMUTH; CADMIUM; CALCIUM; CISPLATIN; COPPER; EDETIC ACID; IRON; MAGNESIUM; SELENIUM; TRACE METAL; VANADIUM; ZINC;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CHELATION; CYTOTOXICITY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; OVARY CANCER; TREATMENT OUTCOME;

EID: 0030906512     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-997-0145-8     Document Type: Article

References (10)

1. Andrews, P. A.; Howell, S. B. Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 2:35-43; 1990.
2. Borenfreund, E.; Puerner, J. A. Toxicity determined in vitro by morphological alterations and neutral red absorption. Tox. Let. 24:(2-3):119-24; 1985.
3. Borenfreund, E.; Puerner, J. A. Cytotoxicity of metals, metal-metal and metal-chelator combinations assayed in vitro. Toxicology 39:121-134; 1986.
4. Cannistra, S. A. Cancer of the ovary. N. Engl. J. Med. 329:1550-1559; 1993.
5. Cherian, M. G.; Howell, S. B.; Inura, N., et al. Role of metallothionein in carcinogenesis. Toxicol. Appl. Pharmacol. 126:1-5; 1994.
6. Dwyer, F. P.; Mellor, D. P. Chelating agents and metal chelates. New York: Academic Press; 1964:17-27.
7. Eastman, A. The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol. & Ther. 34:155-166; 1987.
8. Farrell, N. Structurally novel platinum antitumor compounds. In: Howell, S. B., ed. Platinum and other metal coordination compounds in cancer chemotherapy. New York: Plenum Press; 1991:81-92.
9. Kondo, Y.; Satoh, M.; Imura, N., et al. Tissue-specific induction of metallothionein by bismuth as a promising protocol for chemotherapy with repeated administration of cis-diamminedichloroplatinum (II) against bladder tumor. Anticancer Res. 12:2303-2308; 1992.
10. Lemaire, M. A.; Schwartz, A.; Rahmouni, A. R., et al. Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA. Proc. Natl. Acad. Sci. 88:1982-1985; 1991.